Article info
PDFUnexpected outcome (positive or negative) including adverse drug reactions
Case report
Disseminated cryptococcal disease during treatment with idelalisib and corticosteroids for follicular lymphoma
- Correspondence to Paul J Hengeveld; p.hengeveld{at}erasmusmc.nl
Citation
Disseminated cryptococcal disease during treatment with idelalisib and corticosteroids for follicular lymphoma
Publication history
- Accepted June 15, 2020
- First published July 5, 2020.
Online issue publication
July 05, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.